Articles

David H. Vesole, MD, PhD, discusses the evolution of multiple myeloma treatment, and explained how other BCMA-therapies are poised to impact clinical practice.

Monoclonal Antibodies, ADCs, and CAR T Cells Invigorate the Myeloma Paradigm

Videos

Lori A. Leslie, MD, discusses developments in CAR T-cell therapy in diffuse large B-cell lymphoma and mantle cell lymphoma.

Dr. Leslie on the Development of CAR T-Cell Therapy in DLBCL and MCL

Lori A. Leslie, MD, lymphoma attending, John Theurer Cancer Center, discusses sequencing strategies with zanubrutinib  in mantle cell lymphoma.

Dr. Leslie on Sequencing Zanubrutinib in MCL

Lori A. Leslie, MD, discusses the importance of clinical trials in finding novel, up-front therapy options for patients with mantle cell lymphoma.

Dr. Leslie on the Need for Clinical Trials to Address Unmet Needs in MCL

Lori A. Leslie, MD, discusses the role of zanubrutinib in mantle cell lymphoma.

Dr. Leslie on the Role of Zanubrutinib in MCL 

Lori A. Leslie, MD, discusses the utility of BTK inhibitors in B-cell malignancies.

John Theurer Cancer Center

Latest from John Theurer Cancer Center

New content coming soon, please check back later.